- Home
- NTZ vs TPST Comparison
NTZ vs TPST Comparison
Compare NTZ & TPST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NTZ
- TPST
- Stock Information
- Founded
- NTZ 1959
- TPST 2011
- Country
- NTZ Italy
- TPST United States
- Employees
- NTZ N/A
- TPST N/A
- Industry
- NTZ Home Furnishings
- TPST Biotechnology: Pharmaceutical Preparations
- Sector
- NTZ Consumer Discretionary
- TPST Health Care
- Exchange
- NTZ Nasdaq
- TPST Nasdaq
- Market Cap
- NTZ 31.2M
- TPST 33.0M
- IPO Year
- NTZ 1993
- TPST N/A
- Fundamental
- Price
- NTZ $2.92
- TPST $10.22
- Analyst Decision
- NTZ
- TPST Hold
- Analyst Count
- NTZ 0
- TPST 3
- Target Price
- NTZ N/A
- TPST $30.00
- AVG Volume (30 Days)
- NTZ 7.3K
- TPST 86.0K
- Earning Date
- NTZ 10-21-2025
- TPST 08-11-2025
- Dividend Yield
- NTZ N/A
- TPST N/A
- EPS Growth
- NTZ N/A
- TPST N/A
- EPS
- NTZ N/A
- TPST N/A
- Revenue
- NTZ $337,653,480.00
- TPST N/A
- Revenue This Year
- NTZ N/A
- TPST N/A
- Revenue Next Year
- NTZ N/A
- TPST N/A
- P/E Ratio
- NTZ N/A
- TPST N/A
- Revenue Growth
- NTZ N/A
- TPST N/A
- 52 Week Low
- NTZ $2.15
- TPST $5.35
- 52 Week High
- NTZ $6.27
- TPST $20.67
- Technical
- Relative Strength Index (RSI)
- NTZ 50.04
- TPST 61.09
- Support Level
- NTZ $2.70
- TPST $9.05
- Resistance Level
- NTZ $3.07
- TPST $11.38
- Average True Range (ATR)
- NTZ 0.15
- TPST 0.81
- MACD
- NTZ 0.04
- TPST 0.01
- Stochastic Oscillator
- NTZ 39.81
- TPST 57.17
About NTZ Natuzzi S.p.A.
Natuzzi SpA is an Italian firm that designs, manufactures, and sells contemporary and traditional leather and fabric-upholstered furniture. Its product portfolio includes sofas, loveseats, armchairs, sectional furniture, motion furniture and sofa beds, living room furnishings, and accessories. The company markets its products under several brands such as Natuzzi Italia, Private label, and Natuzzi Editions. Geographically, it derives a majority of its revenue from the United States of America and also has an international presence in Italy, Spain, the UK, China, and Other countries.
About TPST Tempest Therapeutics Inc.
Tempest Therapeutics Inc is a late-stage develpment biotechnology company developing small molecule therapeutics to treat cancer through mechanisms that directly kill tumor cells and activate tumor-specific immunity. Its clinical-stage therapeutic product candidates are TPST-1120 and TPST-1495 which are clinical-stage molecules designed to inhibit their respective targets.